Q2 solutions, an iqvia and quest diagnostics joint venture, teams with adaptive biotechnologies to market immunoseq® assay, the leading quantitative large-scale immunosequencing solution

Morrisville, n.c.--(business wire)--q2 solutions, a leading global clinical trial laboratory services organization, resulting from an iqvia and quest diagnostics joint venture, today announced a partnership with adaptive biotechnologies, a pioneer and leader in immune-driven medicine. q2 solutions will offer its customers the immunoseq® assay, adaptive's next-generation sequencing (ngs) based immunosequencing solution, which is used to quantify adaptive immune receptors at high-throughput, leve
IQV Ratings Summary
IQV Quant Ranking